A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 11,899 shares of JAZZ stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,899
Previous 11,899 -0.0%
Holding current value
$1.46 Million
Previous $1.33 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$100.57 - $116.37 $173,885 - $201,203
1,729 Added 17.0%
11,899 $1.33 Million
Q2 2024

Jul 29, 2024

SELL
$103.94 - $118.98 $3.06 Million - $3.51 Million
-29,474 Reduced 74.35%
10,170 $1.09 Million
Q1 2024

Apr 25, 2024

BUY
$115.19 - $132.77 $61,165 - $70,500
531 Added 1.36%
39,644 $4.77 Million
Q4 2023

Jan 30, 2024

BUY
$114.26 - $136.0 $1.01 Million - $1.2 Million
8,814 Added 29.09%
39,113 $4.81 Million
Q3 2023

Oct 25, 2023

SELL
$122.0 - $145.31 $240,828 - $286,841
-1,974 Reduced 6.12%
30,299 $3.92 Million
Q2 2023

Aug 07, 2023

BUY
$122.5 - $147.16 $22,417 - $26,930
183 Added 0.57%
32,273 $4 Million
Q1 2023

May 08, 2023

BUY
$133.98 - $160.47 $3.08 Million - $3.69 Million
23,019 Added 253.76%
32,090 $4.7 Million
Q4 2022

Feb 01, 2023

SELL
$129.72 - $159.85 $86,263 - $106,300
-665 Reduced 6.83%
9,071 $1.45 Million
Q3 2022

Nov 09, 2022

BUY
$126.59 - $161.18 $81,777 - $104,122
646 Added 7.11%
9,736 $1.3 Million
Q2 2022

Aug 09, 2022

SELL
$141.59 - $168.66 $511,281 - $609,031
-3,611 Reduced 28.43%
9,090 $1.42 Million
Q1 2022

Apr 21, 2022

SELL
$129.64 - $160.7 $11.7 Million - $14.5 Million
-90,284 Reduced 87.67%
12,701 $1.98 Million
Q4 2021

Feb 01, 2022

BUY
$119.87 - $145.67 $2.84 Million - $3.45 Million
23,686 Added 29.87%
102,985 $13.1 Million
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $1.42 Million - $2.04 Million
11,032 Added 16.16%
79,299 $10.3 Million
Q2 2021

Jul 30, 2021

BUY
$160.2 - $186.42 $854,506 - $994,364
5,334 Added 8.48%
68,267 $12.1 Million
Q1 2021

May 03, 2021

SELL
$150.19 - $173.5 $1.52 Million - $1.75 Million
-10,115 Reduced 13.85%
62,933 $10.3 Million
Q4 2020

Jan 28, 2021

SELL
$140.71 - $165.05 $3.69 Million - $4.33 Million
-26,205 Reduced 26.4%
73,048 $12.1 Million
Q3 2020

Nov 06, 2020

SELL
$105.46 - $144.13 $1.92 Million - $2.62 Million
-18,194 Reduced 15.49%
99,253 $14.2 Million
Q2 2020

Jul 28, 2020

SELL
$95.68 - $121.88 $1.12 Million - $1.42 Million
-11,654 Reduced 9.03%
117,447 $13 Million
Q1 2020

May 06, 2020

BUY
$87.74 - $152.74 $874,855 - $1.52 Million
9,971 Added 8.37%
129,101 $12.9 Million
Q4 2019

Jan 21, 2020

SELL
$117.65 - $153.73 $9.23 Million - $12.1 Million
-78,469 Reduced 39.71%
119,130 $17.8 Million
Q3 2019

Oct 18, 2019

BUY
$125.18 - $143.24 $8.39 Million - $9.61 Million
67,060 Added 51.37%
197,599 $25.3 Million
Q2 2019

Jul 30, 2019

BUY
$125.55 - $144.48 $2.4 Million - $2.76 Million
19,109 Added 17.15%
130,539 $18.6 Million
Q1 2019

Apr 29, 2019

BUY
$121.81 - $142.95 $1.93 Million - $2.26 Million
15,821 Added 16.55%
111,430 $15.9 Million
Q4 2018

Jan 25, 2019

BUY
$115.94 - $166.74 $53,912 - $77,534
465 Added 0.49%
95,609 $11.9 Million
Q3 2018

Nov 09, 2018

SELL
$161.01 - $180.57 $9.61 Million - $10.8 Million
-59,711 Reduced 38.56%
95,144 $16 Million
Q2 2018

Aug 06, 2018

SELL
$146.33 - $183.18 $2.97 Million - $3.72 Million
-20,311 Reduced 11.6%
154,855 $26.7 Million
Q1 2018

May 03, 2018

BUY
$135.59 - $157.16 $1.31 Million - $1.52 Million
9,689 Added 5.86%
175,166 $26.4 Million
Q4 2017

Jan 31, 2018

SELL
$131.06 - $150.39 $1.33 Million - $1.52 Million
-10,118 Reduced 5.76%
165,477 $22.3 Million
Q3 2017

Nov 08, 2017

BUY
$142.62 - $155.6 $25 Million - $27.3 Million
175,595
175,595 $25.7 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.